Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 51
Filtrar
1.
Expert Rev Endocrinol Metab ; 14(3): 193-202, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-31023107

RESUMEN

INTRODUCTION: Optimising bone health might reduce the burden of both fractures in childhood and fragility fractures in later life. A number of maternal dietary and non-dietary factors have been identified that might influence offspring bone health and represent targets for intervention. AREAS COVERED: This article will outline the accrual of bone mineral throughout the life course and how observational and intervention studies have shown that maternal diet, in particular maternal calcium and 25-hydroxyvitamin D [25(OH)D] status, and lifestyle are associated with offspring bone mineralization. Studies examining the effects of maternal micronutrient supplementation on offspring bone mineral density (BMD) will also be discussed. EXPERT COMMENTARY: There is a wealth of observational evidence relating maternal diet to offspring BMD. However, high quality randomized controlled trials, such as the ongoing MAVIDOS study, are needed before these findings can be definitively translated into public health advice.


Asunto(s)
Enfermedades del Desarrollo Óseo/prevención & control , Calcificación Fisiológica , Fenómenos Fisiologicos Nutricionales Maternos , Lesiones Prenatales/prevención & control , Densidad Ósea , Enfermedades del Desarrollo Óseo/dietoterapia , Calcio de la Dieta/metabolismo , Ensayos Clínicos como Asunto , Suplementos Dietéticos , Femenino , Humanos , Salud Materna , Estudios Observacionales como Asunto , Embarazo , Lesiones Prenatales/dietoterapia , Vitamina D/análogos & derivados , Vitamina D/metabolismo , Deficiencia de Vitamina D/prevención & control
2.
J Nutr Biochem ; 51: 27-39, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29091812

RESUMEN

Researchers are gaining an increasing understanding of host-gut microbiota interactions, but studies of the role of gut microbiota in linear growth are scarce. The aim of this study was to investigate the effect of food restriction and refeeding with different diets on gut microbiota composition in fast-growing rats. Young male Sprague-Dawley rats were fed regular rat chow ad libitum (control group) or subjected to 40% food restriction for 36 days followed by continued restriction or ad libitum refeeding for 24 days. Three different diets were used for refeeding: regular vegetarian protein chow or chow in which the sole source of protein was casein or whey. In the control group, the composition of the microbiota remained stable. Food restriction for 60 days led to a significant change in the gut microbiota at the phylum level, with a reduction in the abundance of Firmicutes and an increase in Bacteroidetes and Proteobacteria. Rats refed with the vegetarian protein diet had a different microbiota composition than rats refed the casein- or whey-based diet. Similarities in the bacterial population were found between rats refed vegetarian protein or a whey-based diet and control rats, and between rats refed a casein-based diet and rats on continued restriction. There was a significant strong correlation between the gut microbiota and growth parameters: humerus length, epiphyseal growth plate height, and levels of insulin-like growth factor 1 and leptin. In conclusion, the type of protein in the diet significantly affects the gut microbiota and, thereby, may affect animal's health.


Asunto(s)
Restricción Calórica/efectos adversos , Caseínas/administración & dosificación , Disbiosis/dietoterapia , Microbioma Gastrointestinal , Suero Lácteo/administración & dosificación , Animales , Bacteroidetes/clasificación , Bacteroidetes/crecimiento & desarrollo , Bacteroidetes/aislamiento & purificación , Enfermedades del Desarrollo Óseo/etiología , Enfermedades del Desarrollo Óseo/patología , Enfermedades del Desarrollo Óseo/prevención & control , Biología Computacional , Dieta Vegetariana , Disbiosis/etiología , Disbiosis/microbiología , Disbiosis/fisiopatología , Heces/microbiología , Firmicutes/clasificación , Firmicutes/crecimiento & desarrollo , Firmicutes/aislamiento & purificación , Trastornos del Crecimiento/etiología , Trastornos del Crecimiento/patología , Trastornos del Crecimiento/prevención & control , Placa de Crecimiento/patología , Masculino , Tipificación Molecular , Proteínas de Vegetales Comestibles/uso terapéutico , Proteobacteria/clasificación , Proteobacteria/crecimiento & desarrollo , Proteobacteria/aislamiento & purificación , Ratas Sprague-Dawley , Aumento de Peso
3.
An Pediatr (Engl Ed) ; 88(3): 136-139, 2018 Mar.
Artículo en Español | MEDLINE | ID: mdl-28479005

RESUMEN

INTRODUCTION: Developmental dysplasia of the hip (DDH) refers to the spectrum of abnormalities of maturation and development of the hip. Breech presentation is associated with DDH. This risk factor can be modified by external cephalic version (ECV). The aim of this study is to evaluate the incidence of DDH in patients who successfully underwent ECV, as well as to evaluate need for these children (breech for a period during gestation) to be included in the DDH screening protocol. MATERIAL AND METHODS: A prospective cohort study was conducted in the Hospital Universitario de Vigo from January 1, 2015 to December 31, 2015. It included children born in cephalic presentation after a successful ECV, as well as children born in breech presentation. They all were screened for DDH by ultrasound examination of the hip. RESULTS: Out of a total of 122 newborns included in the study, ECV was attempted on 67 (54.9%), of which 35 (52.2%) were successful. Out of the 14 children diagnosed with DDH, 3 of those born in cephalic presentation after a successful ECV were found to be normal on physical examination. CONCLUSIONS: Successful ECV is associated with a lower incidence of DDH as regards breech presentation. However, these patients should be included in the DDH screening protocol for the early detection of this disorder.


Asunto(s)
Enfermedades del Desarrollo Óseo/prevención & control , Luxación de la Cadera/prevención & control , Versión Fetal , Enfermedades del Desarrollo Óseo/epidemiología , Enfermedades del Desarrollo Óseo/etiología , Presentación de Nalgas , Femenino , Luxación de la Cadera/epidemiología , Luxación de la Cadera/etiología , Humanos , Incidencia , Recién Nacido , Masculino , Embarazo , Estudios Prospectivos , Factores de Riesgo
4.
Nutr Res ; 36(1): 101-8, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26773786

RESUMEN

A higher incidence of osteopenia is observed among children with inherited metabolic disorders (inborn errors of metabolism, or IEMs) who consume medical food-based diets that restrict natural vitamin D-containing food sources. We evaluated the vitamin D status of children with IEMs who live in the Pacific Northwest with limited sun exposure and determined whether bone mineral density (BMD) in children with phenylketonuria (PKU), the most common IEM, correlated with diet or biochemical markers of bone metabolism. We hypothesized that children with IEMs would have lower serum vitamin D concentrations than controls and that some children with PKU would have reduced bone mineralization. A retrospective record review of 88 patients with IEMs, and 445 children on unrestricted diets (controls) found the 25-hydroxyvitamin D concentrations were normal and not significantly different between groups (IEM patients, 27.1 ± 10.9; controls, 27.6 ± 11.2). Normal BMD at the hip or spine (-2

Asunto(s)
25-Hidroxivitamina D 2/sangre , Densidad Ósea , Enfermedades del Desarrollo Óseo/prevención & control , Calcifediol/sangre , Alimentos Formulados , Errores Innatos del Metabolismo/dietoterapia , Deficiencia de Vitamina D/prevención & control , Centros Médicos Académicos , Adolescente , Adulto , Biomarcadores/sangre , Enfermedades del Desarrollo Óseo/epidemiología , Enfermedades del Desarrollo Óseo/etiología , Niño , Estudios de Cohortes , Estudios Transversales , Registros Electrónicos de Salud , Alimentos Formulados/efectos adversos , Humanos , Incidencia , Errores Innatos del Metabolismo/sangre , Errores Innatos del Metabolismo/fisiopatología , Oregon/epidemiología , Fenilcetonurias/sangre , Fenilcetonurias/dietoterapia , Fenilcetonurias/fisiopatología , Estudios Retrospectivos , Riesgo , Deficiencia de Vitamina D/epidemiología , Deficiencia de Vitamina D/etiología , Adulto Joven
5.
Blood ; 125(10): 1518-9, 2015 Mar 05.
Artículo en Inglés | MEDLINE | ID: mdl-25745184

RESUMEN

In this issue of Blood, Pievani et al have identified a potential solution to the remaining barrier to the success of hematopoietic stem cell transplantation (HSCT) in children with severe phenotype Hurler syndrome (mucopolysaccharidosis type I [MPS I]).


Asunto(s)
Enfermedades del Desarrollo Óseo/prevención & control , Trasplante de Médula Ósea/métodos , Mucopolisacaridosis I/patología , Mucopolisacaridosis I/terapia , Animales , Femenino , Humanos , Masculino
6.
Blood ; 125(10): 1662-71, 2015 Mar 05.
Artículo en Inglés | MEDLINE | ID: mdl-25298037

RESUMEN

Neonatal bone marrow transplantation (BMT) could offer a novel therapeutic opportunity for genetic disorders by providing sustainable levels of the missing protein at birth, thus preventing tissue damage. We tested this concept in mucopolysaccharidosis type I (MPS IH; Hurler syndrome), a lysosomal storage disorder caused by deficiency of α-l-iduronidase. MPS IH is characterized by a broad spectrum of clinical manifestations, including severe progressive skeletal abnormalities. Although BMT increases the life span of patients with MPS IH, musculoskeletal manifestations are only minimally responsive if the timing of BMT delays, suggesting already irreversible bone damage. In this study, we tested the hypothesis that transplanting normal BM into newborn MPS I mice soon after birth can prevent skeletal dysplasia. We observed that neonatal BMT was effective at restoring α-l-iduronidase activity and clearing elevated glycosaminoglycans in blood and multiple organs. At 37 weeks of age, we observed an almost complete normalization of all bone tissue parameters, using radiographic, microcomputed tomography, biochemical, and histological analyses. Overall, the magnitude of improvements correlated with the extent of hematopoietic engraftment. We conclude that BMT at a very early stage in life markedly reduces signs and symptoms of MPS I before they appear.


Asunto(s)
Enfermedades del Desarrollo Óseo/prevención & control , Trasplante de Médula Ósea/métodos , Mucopolisacaridosis I/patología , Mucopolisacaridosis I/terapia , Factores de Edad , Animales , Animales Recién Nacidos , Enfermedades del Desarrollo Óseo/metabolismo , Enfermedades del Desarrollo Óseo/patología , Huesos/metabolismo , Huesos/patología , Modelos Animales de Enfermedad , Femenino , Glicosaminoglicanos/sangre , Glicosaminoglicanos/metabolismo , Humanos , Iduronidasa/genética , Iduronidasa/metabolismo , Recién Nacido , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Mucopolisacaridosis I/genética
7.
J Mol Endocrinol ; 53(1): T35-44, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24711646

RESUMEN

Children with inflammatory diseases usually display abnormal growth patterns as well as delayed puberty. This is a result of several factors related to the disease itself, such as malnutrition, hypercortisolism, and elevated levels of pro-inflammatory cytokines. These factors in combination with glucocorticoid treatment contribute to growth retardation during chronic inflammation by systemically affecting the major regulator of growth, the GH/IGF1 axis. However, recent studies have also shown evidence of a direct effect of these factors at the growth plate level. In conditions of chronic inflammation, pro-inflammatory cytokines are upregulated and released into the circulation. The most abundant of these, tumor necrosis factor α, interleukin 1ß (IL1ß), and IL6, are all known to directly act on growth plate cartilage to induce apoptosis and thereby suppress bone growth. Both clinical and experimental studies have shown that growth retardation can partly be rescued when these cytokines are blocked. Therefore, therapy modulating the local actions of these cytokines may be effective for preventing growth failure in patients with chronic inflammatory disorders. In this review, we report the current knowledge of inflammatory cytokines and their role in regulating bone growth.


Asunto(s)
Desarrollo Óseo/fisiología , Citocinas/fisiología , Placa de Crecimiento/crecimiento & desarrollo , Placa de Crecimiento/fisiología , Mediadores de Inflamación/fisiología , Adolescente , Animales , Desarrollo Óseo/efectos de los fármacos , Enfermedades del Desarrollo Óseo/patología , Enfermedades del Desarrollo Óseo/fisiopatología , Enfermedades del Desarrollo Óseo/prevención & control , Niño , Trastornos de la Nutrición del Niño/patología , Trastornos de la Nutrición del Niño/fisiopatología , Citocinas/antagonistas & inhibidores , Glucocorticoides/efectos adversos , Glucocorticoides/fisiología , Placa de Crecimiento/patología , Humanos , Inflamación/patología , Inflamación/fisiopatología , Inflamación/terapia , Mediadores de Inflamación/antagonistas & inhibidores
8.
J Nutr Biochem ; 25(6): 623-33, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24746838

RESUMEN

Omega-3 fatty acids (FAs) are essential nutritional components that must be obtained from foods. Increasing evidence validate that omega-3 FAs are beneficial for bone health, and several mechanisms have been suggested to mediate their effects on bone, including alterations in calcium absorption and urinary calcium loss, prostaglandin synthesis, lipid oxidation, osteoblast formation and inhibition of osteoclastogenesis. However, to date, there is scant information regarding the effect of omega-3 FAs on the developing skeleton during the rapid growth phase. In this study we aim to evaluate the effect of exposure to high levels of omega-3 FAs on bone development and quality during prenatal and early postnatal period. For this purpose, we used the fat-1 transgenic mice that have the ability to convert omega-6 to omega-3 fatty acids and the ATDC5 chondrogenic cell line as models. We show that exposure to high concentrations of omega-3 FAs at a young age accelerates bone growth through alterations of the growth plate, associated with increased chondrocyte proliferation and differentiation. We further propose that those effects are mediated by the receptors G-protein coupled receptor 120 (GPR120) and hepatic nuclear factor 4α, which are expressed by chondrocytes in culture. Additionally, using a combined study on the structural and mechanical bone parameters, we show that high omega-3 levels contribute to superior trabecular and cortical structure, as well as to stiffer bones and improved bone quality. Most interestingly, the fat-1 model allowed us to demonstrate the role of maternal high omega-3 concentration on bone growth during the gestation and postnatal period.


Asunto(s)
Desarrollo Óseo , Enfermedades del Desarrollo Óseo/prevención & control , Huesos/patología , Ácidos Grasos Omega-3/biosíntesis , Osteogénesis , Animales , Densidad Ósea , Enfermedades del Desarrollo Óseo/enzimología , Enfermedades del Desarrollo Óseo/metabolismo , Enfermedades del Desarrollo Óseo/patología , Huesos/citología , Huesos/metabolismo , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Línea Celular , Proliferación Celular , Condrocitos/citología , Condrocitos/metabolismo , Condrocitos/patología , Ácido Graso Desaturasas/genética , Ácido Graso Desaturasas/metabolismo , Ácidos Grasos Omega-3/uso terapéutico , Femenino , Factor Nuclear 4 del Hepatocito/agonistas , Factor Nuclear 4 del Hepatocito/metabolismo , Heterocigoto , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Receptores Acoplados a Proteínas G/agonistas , Receptores Acoplados a Proteínas G/metabolismo , Caracteres Sexuales , Organismos Libres de Patógenos Específicos
9.
Inflamm Bowel Dis ; 19(13): 2919-26, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23974992

RESUMEN

Growth retardation, delayed puberty, decreased bone mass, altered bone architecture, hypovitaminosis D and skeletal muscle mass deficits are common in children with inflammatory bowel diseases. The Crohn's and Colitis Foundation of America sponsored a multidisciplinary workshop on the subject of Bone and Skeletal Growth in Pediatric IBD, held in New York City in November 2011. The topic of the workshop was a key recommendation of the Foundation's Pediatric Challenges meeting in 2005. The Litwin Foundation provided a generous grant to support this crucial research and workshop through the CCFA. The workshop featured 15 presentations by researchers from the United States, Canada, Switzerland, Germany, and the United Kingdom and a number of posters elucidating diverse aspects of the problem of growth retardation and compromised bone health in pediatric Crohn's disease and ulcerative colitis. The workshop comprised original, basic, and clinical research and relevant reviews of underlying genetics, molecular biology, endocrinology, immunology, and bone physiology research. Investigators funded by CCFA and the Litwin Family Foundation are marked by an asterisk after their name in the text. Workshop presentations fell under 3 broad categories: "Mechanisms of Suppression and Growth of Bone Cell Function by Inflammation," "Impact of IBD on Growth and Bone Health," and "Approaches to Address Growth Failure and Low Bone Mass in Children with IBD," summarized herein. We have cited the publications that resulted from this granting mechanism in the appropriate section and references for pertinent updates on each topic.


Asunto(s)
Enfermedades del Desarrollo Óseo/prevención & control , Colitis Ulcerosa/fisiopatología , Enfermedad de Crohn/fisiopatología , Trastornos del Crecimiento/prevención & control , Enfermedades Musculares/prevención & control , Niño , Humanos , Informe de Investigación
10.
Rev Invest Clin ; 65(1): 39-51, 2013.
Artículo en Español | MEDLINE | ID: mdl-23745443

RESUMEN

INTRODUCTION: Propranolol (P) treatment exerts a preventive effect against the detrimental consequences to bone status in mildly chronically food-restricted growing rats (NGR) by an increment in cortical bone and by improving its spatial distribution. OBJECTIVE: To study the effect of beta-blocker on operational mechanism of bone mechanostat in an animal model of nutritional stress. MATERIAL AND METHODS: Weanling male Wistar rats were randomly assigned to four groups: control (C), C + P (CP), NGR and NGR + P (NGRP). C and CP rats were fed freely with the standard diet. NGR and NGRP rats received, for 4 weeks, 80% of the amount of food consumed by C and CP respectively, the previous day, corrected by body weight. Propranolol (7 mg/kg/day) was injected ip 5 days per week, for four weeks in CP and NGRP rats. C and NGR received saline injections at an identical dosage regimen. Body weight and length were determined during the experimental period. Dietary intake was registered daily. Animals were sacrificed after 4 weeks of food restriction. Immediately, cuadriceps, femur and tibiae from each animal were dissected and weighed, and histomorphometric and mechanical studies were performed. Serum a-CTX, osteocalcin, intact PTH, calcium and phosphorous were determined. Body protein (% prot) was measured in all groups. RESULTS: Food restriction induced detrimental effects on body and femoral growth, load-bearing capacity (Wf), % prot and cuadriceps weight in NGR us. C (p < 0.01). beta-blocker did not modify anthropometric and bone morphometric parameters in NGRP and CP us. NGR and C, respectively (p > 0.05). However, Wf NGRP vs. NGR was significantly higher (p < 0.01). alpha-CTX was significantly higher in NGR vs. C (p < 0.01). No significant differences were observed in alpha-CTX levels between CP, NGRP and C (p > 0.05). Serum osteocalcin, intact PTH, calcium and phospho- rous showed no significant difference between groups (p > 0.05). CONCLUSION: These results suggest that modeling increase in bone mass and strength in NGRP rats could be due to an anticatabolic interaction of the beta-blocker propranolol on operational mechanism of bone mechanostat in an animal model of nutritional stress.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Enfermedades del Desarrollo Óseo/prevención & control , Privación de Alimentos/fisiología , Trastornos del Crecimiento/prevención & control , Desnutrición/fisiopatología , Propranolol/uso terapéutico , Antagonistas Adrenérgicos beta/farmacología , Animales , Biomarcadores , Peso Corporal/efectos de los fármacos , Enfermedades del Desarrollo Óseo/sangre , Enfermedades del Desarrollo Óseo/etiología , Enfermedades del Desarrollo Óseo/patología , Remodelación Ósea/efectos de los fármacos , Colágeno Tipo I/sangre , Módulo de Elasticidad/efectos de los fármacos , Fémur/efectos de los fármacos , Fémur/patología , Trastornos del Crecimiento/sangre , Trastornos del Crecimiento/etiología , Trastornos del Crecimiento/patología , Masculino , Desnutrición/tratamiento farmacológico , Minerales/sangre , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/patología , Tamaño de los Órganos/efectos de los fármacos , Hormona Paratiroidea/sangre , Péptidos/sangre , Propranolol/farmacología , Proteínas/análisis , Distribución Aleatoria , Ratas , Ratas Wistar , Soporte de Peso
11.
J Pediatr Endocrinol Metab ; 24(7-8): 543-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21932595

RESUMEN

OBJECTIVE: To develop a reliable and accurate preimplantation genetic diagnosis (PGD) method in six families with endocrine diseases: persistent hyperinsulinemic hypoglycemia of infancy (PHHI), congenital adrenal hyperplasia (CAH) salt-wasting form, Sanjat-Sakati syndrome and multiple endocrine neoplasia 2A (MEN 2A). METHODS: For each disease a battery of at least four informative markers surrounding the tested gene were identified and for each family a protocol of multiplex fluorescent markers was developed and performed on single cells. RESULTS: PGD for PHHI was performed in three families. In family 1 two healthy children were born from different cycles, in family 2 three healthy children were born from two cycles, and in family 3 a healthy boy was born. For CAH in one family a healthy girl was born. One PGD cycle for Sanjat-Sakati resulted in a clinical pregnancy that was terminated due to high nuccal translucency (46X0). For one family with MEN 2A disease, the eighth PGD cycle resulted in birth of healthy twins. In all children genetic confirmation of the healthy status was performed. CONCLUSIONS: PGD is an effective method for preventing birth of affected children with endocrine disorders. Increasing the awareness of clinicians to the availability of these methods is most important.


Asunto(s)
Enfermedades del Desarrollo Óseo/genética , Enfermedades del Desarrollo Óseo/prevención & control , Enfermedades del Sistema Endocrino/genética , Enfermedades del Sistema Endocrino/prevención & control , Enfermedades Pancreáticas/genética , Enfermedades Pancreáticas/prevención & control , Diagnóstico Preimplantación/métodos , Anomalías Múltiples/genética , Anomalías Múltiples/prevención & control , Hiperplasia Suprarrenal Congénita/genética , Hiperplasia Suprarrenal Congénita/prevención & control , Adulto , Enfermedades del Desarrollo Óseo/congénito , Hiperinsulinismo Congénito , Transferencia de Embrión , Enfermedades del Sistema Endocrino/congénito , Salud de la Familia , Femenino , Marcadores Genéticos , Trastornos del Crecimiento/congénito , Trastornos del Crecimiento/genética , Trastornos del Crecimiento/prevención & control , Humanos , Hipoparatiroidismo/congénito , Hipoparatiroidismo/genética , Hipoparatiroidismo/prevención & control , Discapacidad Intelectual/genética , Discapacidad Intelectual/prevención & control , Israel , Masculino , Neoplasia Endocrina Múltiple Tipo 2a/congénito , Neoplasia Endocrina Múltiple Tipo 2a/genética , Neoplasia Endocrina Múltiple Tipo 2a/prevención & control , Nesidioblastosis/congénito , Nesidioblastosis/genética , Nesidioblastosis/prevención & control , Osteocondrodisplasias/congénito , Osteocondrodisplasias/genética , Osteocondrodisplasias/prevención & control , Enfermedades Pancreáticas/congénito , Embarazo , Resultado del Embarazo , Convulsiones/congénito , Convulsiones/genética , Convulsiones/prevención & control
12.
J Matern Fetal Neonatal Med ; 24 Suppl 1: 7-11, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21942582

RESUMEN

Vitamin D has an important role in bone-metabolism (and its deficiency can cause preterm osteopenia, craniotabe and rickets), but it has also non-calcitropic functions. In fact, vitamin D deficiency is correlated to chronic kidney disease, respiratory infections, type 1 diabetes, psoriasis, Crohn disease and neonatal hypocalcemia. Because of the vitamin D deficiency is a global problem, its role as a drug is fundamental for the human health in all ages.


Asunto(s)
Deficiencia de Vitamina D/tratamiento farmacológico , Vitamina D/uso terapéutico , Enfermedades del Desarrollo Óseo/sangre , Enfermedades del Desarrollo Óseo/etiología , Enfermedades del Desarrollo Óseo/prevención & control , Niño , Enfermedad de Crohn/tratamiento farmacológico , Enfermedad de Crohn/etiología , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 1/etiología , Humanos , Hipocalcemia/sangre , Hipocalcemia/congénito , Hipocalcemia/tratamiento farmacológico , Recién Nacido , Enfermedades del Recién Nacido/tratamiento farmacológico , Fallo Renal Crónico/tratamiento farmacológico , Raquitismo/tratamiento farmacológico , Raquitismo/etiología , Vitamina D/sangre , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/diagnóstico , Deficiencia de Vitamina D/epidemiología
13.
Clin Calcium ; 20(6): 872-80, 2010 Jun.
Artículo en Japonés | MEDLINE | ID: mdl-20513945

RESUMEN

Recently, opposing trends have appeared to be either excessiveness or lack in the frequency of exercise or sports during childhood, both of which are believed to be associated with various sports-related injuries. In childhood, the bones, muscles, and ligaments are developing and not yet matured; though soft and flexible, their relative low strength is inadequate to tolerate abnormal external forces. Although a child's body normally has substantial self-healing ability, there is the risk of causing a lifelong deformity or growth disorder if not treated properly. A comprehensively organized system for the prevention, early detection, and treatment of bone and joint disorders in children should be developed in the future.


Asunto(s)
Traumatismos en Atletas/etiología , Enfermedades del Desarrollo Óseo/etiología , Artropatías/etiología , Deportes , Traumatismos en Atletas/diagnóstico , Traumatismos en Atletas/prevención & control , Traumatismos en Atletas/terapia , Desarrollo Óseo , Enfermedades del Desarrollo Óseo/diagnóstico , Enfermedades del Desarrollo Óseo/prevención & control , Enfermedades del Desarrollo Óseo/terapia , Niño , Humanos , Artropatías/diagnóstico , Artropatías/prevención & control , Artropatías/terapia , Articulaciones/crecimiento & desarrollo
14.
J Bone Joint Surg Br ; 91(5): 655-8, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19407302

RESUMEN

In a prospective study over 11 years we assessed the relationship between neonatal deformities of the foot and the presence of ultrasonographic developmental dysplasia of the hip (DDH). Between 1 January 1996 and 31 December 2006, 614 infants with deformities of the foot were referred for clinical and ultrasonographic evaluation. There were 436 cases of postural talipes equinovarus deformity (TEV), 60 of fixed congenital talipes equinovarus (CTEV), 93 of congenital talipes calcaneovalgus (CTCV) and 25 of metatarsus adductus. The overall risk of ultrasonographic dysplasia or instability was 1:27 in postural TEV, 1:8.6 in CTEV, 1:5.2 in CTCV and 1:25 in metatarsus adductus. The risk of type-IV instability of the hip or irreducible dislocation was 1:436 (0.2%) in postural TEV, 1:15.4 (6.5%) in CTCV and 1:25 (4%) in metatarsus adductus. There were no cases of hip instability (type IV) or of irreducible dislocation in the CTEV group. Routine screening for DDH in cases of postural TEV and CTEV is no longer advocated. The former is poorly defined, leading to the over-diagnosis of a possibly spurious condition. Ultrasonographic imaging and surveillance of hips in infants with CTCV and possibly those with metatarsus adductus should continue.


Asunto(s)
Enfermedades del Desarrollo Óseo/epidemiología , Deformidades Congénitas del Pie/epidemiología , Luxación Congénita de la Cadera/epidemiología , Inestabilidad de la Articulación/epidemiología , Enfermedades del Desarrollo Óseo/prevención & control , Luxación Congénita de la Cadera/prevención & control , Articulación de la Cadera/diagnóstico por imagen , Humanos , Lactante , Recién Nacido , Inestabilidad de la Articulación/diagnóstico por imagen , Estudios Longitudinales , Tamizaje Neonatal/métodos , Guías de Práctica Clínica como Asunto , Estudios Prospectivos , Derivación y Consulta , Factores de Riesgo , Ultrasonografía , Reino Unido/epidemiología
15.
Am J Med Genet C Semin Med Genet ; 145C(3): 309-21, 2007 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-17639591

RESUMEN

The bone dysplasias are a heterogeneous group of disorders arising from intrinsic abnormality of bone and cartilage growth and function. All are genetic. Most result in extreme small stature (dwarfism). Historically, emphasis was primarily on diagnostic identification of specific disorders in infants (including differentiating lethal and non-lethal forms), and on the clinical history to be anticipated in infants and children with each of these specific processes. Even in children there is exceedingly limited information of quality and virtually no controlled studies of the effects of intervention. For the most part, information about affected adults is even less complete and even less rigorous. Presented here are a series of examples of medical and adaptive issues in adults affected by one or another of the genetic skeletal dysplasias. Topics discussed include: approach to adults with no specific diagnosis; medical issues that cross diagnostic boundaries (osteoarthritis in the "E" disorders, obstructive apnea, issues in pregnancy in women with dwarfing disorders, activities of daily living, and quality of life assessments); diagnosis-specific problems of adulthood (spinal stenosis in achondroplasia, hearing loss in osteogenesis imperfecta, and malignancy risk in multiple exostoses); adult problems that must be addressed in childhood in order to be prevented (achondroplasia and kyphosis, and cervical spine abnormalities in Morquio syndrome); survival conundrums (why some live unexpectedly and others die unexpectedly). Emphasis is placed on the difficulties intrinsic to trying to learn about needs and expectations in generally rare genetic processes.


Asunto(s)
Enfermedades del Desarrollo Óseo/diagnóstico , Adulto , Enfermedades del Desarrollo Óseo/mortalidad , Enfermedades del Desarrollo Óseo/prevención & control , Enfermedades del Desarrollo Óseo/terapia , Humanos
17.
In. Bolivia. Instituto de Maternidad Dr. Percy Boland Rodríguez. Memorias y publicaciones científicas: Instituto de Maternidad Dotor Percy Boland Rodríguez 2000. Santa Cruz, MPB, 2 ed; oct. 2000. p.49-49.
Monografía en Español | LILACS | ID: lil-307056

RESUMEN

Este artículo refleja un estudio prospectivo sobre las displasias en papanicolao de rutina


Asunto(s)
Enfermedades del Desarrollo Óseo/prevención & control , Bolivia , Investigación
19.
Scand J Med Sci Sports ; 7(6): 363-6, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9458504

RESUMEN

Wrist pain is a common complaint in gymnasts. Repetitive stress on the distal radial physis may lead to either gradual slipping of the epiphysis or growth disturbances. In some cases growth disturbances of the distal radial physis lead to triangulation of the distal radius and secondary ulnar overgrowth, and eventually a Madelung-like deformity. The present case report is the first to describe the outcome of epiphysiodesis of the distal radial and ulnar growth plates in a skeletally immature gymnast as a surgical treatment to prevent Madelung's deformity.


Asunto(s)
Trastornos de Traumas Acumulados/cirugía , Epífisis/cirugía , Placa de Crecimiento/cirugía , Gimnasia/lesiones , Radio (Anatomía)/cirugía , Cúbito/cirugía , Traumatismos de la Muñeca/cirugía , Adolescente , Enfermedades del Desarrollo Óseo/etiología , Enfermedades del Desarrollo Óseo/prevención & control , Epífisis/lesiones , Epífisis Desprendida/etiología , Femenino , Estudios de Seguimiento , Deformidades de la Mano/etiología , Deformidades de la Mano/prevención & control , Humanos , Artropatías/etiología , Artropatías/prevención & control , Radio (Anatomía)/lesiones , Fracturas de Salter-Harris , Resultado del Tratamiento , Cúbito/lesiones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA